Cargando…
Regarding Journal of Thoracic Disease Vol 12, Supplement 1 (February 2020) (Sepsis: Science and Fiction)—Driving blind: instituting SEP-1 without high quality outcomes data
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264683/ https://www.ncbi.nlm.nih.gov/pubmed/34277084 http://dx.doi.org/10.21037/jtd-2021-29 |
| _version_ | 1783719613297590272 |
|---|---|
| author | Townsend, Sean R. |
| author_facet | Townsend, Sean R. |
| author_sort | Townsend, Sean R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8264683 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82646832021-07-16 Regarding Journal of Thoracic Disease Vol 12, Supplement 1 (February 2020) (Sepsis: Science and Fiction)—Driving blind: instituting SEP-1 without high quality outcomes data Townsend, Sean R. J Thorac Dis Letter to the Editor AME Publishing Company 2021-06 /pmc/articles/PMC8264683/ /pubmed/34277084 http://dx.doi.org/10.21037/jtd-2021-29 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Letter to the Editor Townsend, Sean R. Regarding Journal of Thoracic Disease Vol 12, Supplement 1 (February 2020) (Sepsis: Science and Fiction)—Driving blind: instituting SEP-1 without high quality outcomes data |
| title | Regarding Journal of Thoracic Disease Vol 12, Supplement 1 (February 2020) (Sepsis: Science and Fiction)—Driving blind: instituting SEP-1 without high quality outcomes data |
| title_full | Regarding Journal of Thoracic Disease Vol 12, Supplement 1 (February 2020) (Sepsis: Science and Fiction)—Driving blind: instituting SEP-1 without high quality outcomes data |
| title_fullStr | Regarding Journal of Thoracic Disease Vol 12, Supplement 1 (February 2020) (Sepsis: Science and Fiction)—Driving blind: instituting SEP-1 without high quality outcomes data |
| title_full_unstemmed | Regarding Journal of Thoracic Disease Vol 12, Supplement 1 (February 2020) (Sepsis: Science and Fiction)—Driving blind: instituting SEP-1 without high quality outcomes data |
| title_short | Regarding Journal of Thoracic Disease Vol 12, Supplement 1 (February 2020) (Sepsis: Science and Fiction)—Driving blind: instituting SEP-1 without high quality outcomes data |
| title_sort | regarding journal of thoracic disease vol 12, supplement 1 (february 2020) (sepsis: science and fiction)—driving blind: instituting sep-1 without high quality outcomes data |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264683/ https://www.ncbi.nlm.nih.gov/pubmed/34277084 http://dx.doi.org/10.21037/jtd-2021-29 |
| work_keys_str_mv | AT townsendseanr regardingjournalofthoracicdiseasevol12supplement1february2020sepsisscienceandfictiondrivingblindinstitutingsep1withouthighqualityoutcomesdata |